Trevena, Inc. (TRVN)

Check out top investors' recommendation for TRVN
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
9.00
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
100%/0%
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
Trevena, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing therapeutics for G protein coupled receptors. Its products include TRV027 that has completed Phase 2a clinical trials for the treatment of acute heart failure; TRV130, a small molecule G protein biased ligand at the
Sector:
Industry:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Ed Arce Mcnicoll, Lewis, & Vlak Buy   Oct 12, '18     3.00  Oct 12, '19  N/A 
Jason Butler JMP Securities Buy   Oct 10, '18     15.00  Oct 10, '19  N/A 
Ritu Baral Canaccord Genuity Buy   Sep 04, '18     10.00  Sep 04, '19  N/A 
Jason Butler JMP Securities Buy   Aug 20, '18     15.00  Aug 20, '19  N/A 
Ed Arce Mcnicoll, Lewis, & Vlak Buy   Aug 13, '18     7.00  Aug 13, '19  N/A 
Ritu Baral Canaccord Genuity Buy   Jun 05, '18     10.00  Jun 05, '19  N/A 
Ed Arce Mcnicoll, Lewis, & Vlak Buy   Mar 08, '18     7.00  Mar 08, '19  N/A 
Alan Carr Needham & Company Buy   Nov 07, '17     7.00  Nov 07, '18  N/A 
Ed Arce Mcnicoll, Lewis, & Vlak Buy   Oct 12, '17     7.00  Oct 12, '18  N/A 
Ritu Baral Canaccord Genuity Buy   Aug 03, '17     10.00  Aug 03, '18  N/A 
Alan Carr Needham & Company Buy   Aug 03, '17       Aug 03, '18  N/A 
Ed Arce Mcnicoll, Lewis, & Vlak Buy   Jul 21, '17     8.00  Jul 21, '18  N/A 
Alan Carr Needham & Company Buy   Feb 21, '17     11.00  Feb 21, '18  N/A 
Ritu Baral Canaccord Genuity Buy   Jan 25, '17     13.00  Jan 25, '18  N/A 
Biren Amin Jefferies & Co. Buy   Nov 03, '16     11.00  Nov 03, '17  N/A 
Jonathan Aschoff Brean Murray, Carret & Co. Buy   Mar 09, '16   7.71  14.00  Mar 09, '17  -54.22% 
Jason Butler JMP Securities Buy   Mar 09, '16   7.71  18.00  Mar 09, '17  -54.22% 
Biren Amin Jefferies & Co. Buy   Feb 22, '16   9.71  15.00  Feb 22, '17  -56.02% 
Ritu Baral Canaccord Genuity Buy   Feb 22, '16   9.71  14.00  Feb 22, '17  -56.02% 
Alan Carr Needham & Company Buy   Oct 29, '15   9.89  14.00  Oct 29, '16  -49.14% 
< previous12